ICON Insider Trades
NASDAQ: ICLRHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 37 · $4.04M
- Shares bought / sold
- 0 / 23.71K
- Net activity
- Net selling $4.0 million
ICON insider activity
Over the last 12 months, ICON insiders reported 50 transactions on SEC Form 4: 0 open-market purchases and 37 sales. Insiders bought $0 and sold $4.0 million worth of stock, for net insider selling of $4.0 million. The largest seller was CLIMAX JOHN DR, with $1.0 million in reported sales.
The most recent filing shows Murphy Ronan Martin (Director) reporting a transaction in 5,005 shares at $125.74 on Sep 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ICLR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ICLR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 17, 2026 | McCague Eugene PacelliDirector | Sale | 3,255 | $569.63K | Form 4 |
| Sep 17, 2026 | McCague Eugene PacelliDirector | Option exercise | 3,255 | $409.28K | Form 4 |
| Sep 17, 2026 | Murphy Ronan MartinDirector | Sale | 5,005 | $875.88K | Form 4 |
| Sep 17, 2026 | Murphy Ronan MartinDirector | Option exercise | 5,005 | $629.33K | Form 4 |
| Sep 16, 2026 | CLIMAX JOHN DRDirector | Sale | 5,005 | $875.88K | Form 4 |
| Sep 16, 2026 | CLIMAX JOHN DRDirector | Option exercise | 5,005 | $629.33K | Form 4 |
| Aug 11, 2026 | McCague Eugene PacelliDirector | Sale | 67 | $11.09K | Form 4 |
| Aug 11, 2026 | McCague Eugene PacelliDirector | Sale | 590 | $97.04K | Form 4 |
| Aug 11, 2026 | McCague Eugene PacelliDirector | Sale | 96 | $15.72K | Form 4 |
| Aug 11, 2026 | McCague Eugene PacelliDirector | Sale | 88 | $14.32K | Form 4 |
| Aug 11, 2026 | Murray CiaranDirector | Sale | 212 | $35.09K | Form 4 |
| Aug 11, 2026 | Murray CiaranDirector | Sale | 1,880 | $309.20K | Form 4 |
| Aug 11, 2026 | Murray CiaranDirector | Sale | 305 | $49.95K | Form 4 |
| Aug 11, 2026 | Murray CiaranDirector | Sale | 280 | $45.56K | Form 4 |
| Aug 11, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Sale | 180 | $29.79K | Form 4 |
| Aug 11, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Sale | 1,591 | $261.67K | Form 4 |
| Aug 11, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Sale | 259 | $42.42K | Form 4 |
| Aug 11, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Sale | 237 | $38.56K | Form 4 |
| Aug 11, 2026 | CLIMAX JOHN DRDirector | Sale | 67 | $11.09K | Form 4 |
| Aug 11, 2026 | CLIMAX JOHN DRDirector | Sale | 591 | $97.20K | Form 4 |
| Aug 11, 2026 | CLIMAX JOHN DRDirector | Sale | 95 | $15.56K | Form 4 |
| Aug 11, 2026 | CLIMAX JOHN DRDirector | Sale | 88 | $14.32K | Form 4 |
| Aug 11, 2026 | Grais LindaDirector | Sale | 67 | $11.09K | Form 4 |
| Aug 11, 2026 | Grais LindaDirector | Sale | 590 | $97.04K | Form 4 |
| Aug 11, 2026 | Grais LindaDirector | Sale | 97 | $15.89K | Form 4 |
| Aug 11, 2026 | Grais LindaDirector | Sale | 87 | $14.16K | Form 4 |
| Aug 11, 2026 | Murphy Ronan MartinDirector | Sale | 67 | $11.09K | Form 4 |
| Aug 11, 2026 | Murphy Ronan MartinDirector | Sale | 590 | $97.04K | Form 4 |
| Aug 11, 2026 | Murphy Ronan MartinDirector | Sale | 96 | $15.72K | Form 4 |
| Aug 11, 2026 | Murphy Ronan MartinDirector | Sale | 88 | $14.32K | Form 4 |
| Aug 11, 2026 | O'Neill JulieDirector | Sale | 73 | $12.08K | Form 4 |
| Aug 11, 2026 | O'Neill JulieDirector | Sale | 642 | $105.59K | Form 4 |
| Aug 11, 2026 | O'Neill JulieDirector | Sale | 105 | $17.20K | Form 4 |
| Aug 11, 2026 | O'Neill JulieDirector | Sale | 95 | $15.46K | Form 4 |
| Aug 11, 2026 | Whitaker Anne ClemDirector | Sale | 67 | $11.09K | Form 4 |
| Aug 11, 2026 | Whitaker Anne ClemDirector | Sale | 590 | $97.04K | Form 4 |
| Aug 11, 2026 | Whitaker Anne ClemDirector | Sale | 96 | $15.72K | Form 4 |
| Aug 11, 2026 | Whitaker Anne ClemDirector | Sale | 88 | $14.32K | Form 4 |
| Aug 10, 2026 | Balfe Barry EdwardChief Executive Officer | Sale | 78 | $12.88K | Form 4 |
| Aug 10, 2026 | Balfe Barry EdwardChief Executive Officer | Sale | 304 | $49.80K | Form 4 |
| Aug 10, 2026 | McCague Eugene PacelliDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 10, 2026 | Murray CiaranDirector | Option exercise | 2,677 | — | Form 4 |
| Aug 10, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Option exercise | 3,375 | — | Form 4 |
| Aug 10, 2026 | Clerkin Nigel Bernard JohnChief Financial Officer | Option exercise | 918 | — | Form 4 |
| Aug 10, 2026 | CLIMAX JOHN DRDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 10, 2026 | Grais LindaDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 10, 2026 | Murphy Ronan MartinDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 10, 2026 | O'Neill JulieDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 10, 2026 | Whitaker Anne ClemDirector | Option exercise | 1,732 | — | Form 4 |
| Aug 7, 2026 | Balfe Barry EdwardChief Executive Officer | Option exercise | 728 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4